Remission of idiopathic retroperitoneal fibrosis by ofatumumab as a disease-modifying therapy for multiple sclerosis

• Akira Hanazono,
• Yui Sanpei,
• Hinako Shimada,
• Keita Yasuda,
• Yoshiko Takahashi,
• Homare Funasaka,
• Ryuichiro Sagehashi,
• Yuko Hiroshima,
• Hiroshi Nanjo,
• Masashiro Sugawara

Affiliations

Akira Hanazono

Akita University Graduate School of Medicine, Department of Neurology, Japan; Corresponding author.

Yui Sanpei

Akita University Graduate School of Medicine, Department of Neurology, Japan

Hinako Shimada

Akita University Graduate School of Medicine, Department of Neurology, Japan

Keita Yasuda

Akita University Graduate School of Medicine, Department of Neurology, Japan

Yoshiko Takahashi

Akita University Graduate School of Medicine, Department of Neurology, Japan

Homare Funasaka

Akita University Graduate School of Medicine, Department of Neurology, Japan

Ryuichiro Sagehashi

Akita University Graduate School of Medicine, Department of Urology, Japan

Yuko Hiroshima

Akita University Hospital, Division of Clinical Pathology, Japan

Hiroshi Nanjo

Akita University Hospital, Division of Clinical Pathology, Japan

Masashiro Sugawara

Akita University Graduate School of Medicine, Department of Neurology, Japan